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The Slit-Robo GTPase-activating protein 3 (srGAP3) has been implicated in different critical aspects
of neuronal development. These ﬁndings have mainly been based on the characterisation of the
three conserved globular N-terminal domains, while the function of the C-terminal region (CTR)
is still unknown. We show that this predicted unstructured region acts as an adaptor by binding
to the endocytic proteins Amphiphysin, Endophilin-A2, Endophilin-A1, as well as the Ras signalling
protein Grb2. All these interactions depend on a single proline-rich motif in the CTR and the
Src-homology 3 domains of the binding partners. Via these interactions srGAP3 could link receptor
signalling events to the endocytic machinery.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Efﬁcient cellular signalling depends on the cooperative assem-
bly of multi-protein complexes [1], which enable highly combina-
torial decision making through mostly transient protein–protein
interactions [1–3]. Therefore, many signalling proteins are
equipped with small adaptor domains, such as Src-homology 3
(SH3) domains, which recognise short peptide stretches (termed
linear motifs) with moderate afﬁnity and speciﬁcity [4–7]. The
Slit-Robo GTPase-activating proteins (srGAP) have been implicated
in the Slit-Robo pathway, in which they act downstream of Robo
receptors [8–10] and transmit the signal to the actin cytoskeleton
[10]. This family comprises srGAP1, srGAP2, srGAP3, and the more
distantly related ARHGAP4, which share a modular domain
architecture with an N-terminal Fes-Cip4-homology Bin-
Amphiphysin-Rvs (F-BAR) domain followed by a GTPase-activating
(GAP) domain, and an SH3 domain (Fig. 1A) [10]. Despite the high
degree of sequence conservation in these domains [10,11], srGAP
proteins seem to be involved in different aspects of neuronal
development [8,10,12–15]. SrGAP3, which is also termed mentaldisorder GAP (MEGAP) [16] or WAVE-associated RacGAP protein
(WRP) [17], was, for example, found to regulate commissural axon
pathﬁnding [8] and the migration of neuronal progenitors out of
the subventricular zone [14]. On a molecular level, srGAP3 employs
its unique domain composition to regulate a variety of cellular
functions: Via its F-BAR domain it is targeted to membranes [18]
and facilitates outward protrusions, which was found to be crucial
for dendritic spine initiation [19]. The SH3 domain mediates
complex formation with Robo1 and Robo2 [8,20], WAVE-1 [17],
or Lamellipodin [18], thereby enabling signal transmission and –
in addition to the GAP domain – negative regulation of Rac1-
dependent actin polymerisation [10,16–18,21]. While all of these
studies focused on the N-terminal domains, the function of the less
conserved C-terminal region (CTR) [10] has remained elusive.
Employing different biochemical and biophysical methods, we
demonstrate that the CTR of srGAP3 confers binding to the SH3
domain-containing proteins Endophilin-A1, Endophilin-A2,
Amphiphysin, and Grb2 in vivo and in vitro. We ﬁnd that a single
polyproline (PXXP) motif is sufﬁcient for the SH3 domain-
mediated complex formation with all four proteins.
2. Materials and methods
2.1. Cloning
For protein expression in mammalian cells, a modiﬁed pEGFPC2
vector (Clontech) series (termed pEGFPC2P/pmCherryC2P) was
Fig. 1. SrGAP3 interacts with SH3 domain-containing proteins in vivo. (A) Domain
architecture of srGAP3 full-length and the C-terminal region (CTR) fused to GST. F-
BAR, Fes-Cip4-homology-Bin-Amphiphysin-Rvs domain; GAP, GTPase-activating
domain; SH3, Src-homology 3 domain. (B) Co-immunoprecipitation assay.
MCherry-tagged candidate proteins were co-transfected with either eGFP-tagged
srGAP3 or eGFP into HEK293T cells and complex formation was measured with a
ﬂuorescence-based co-immunoprecipitation assay using an immobilised GFP-
nanobody. The average mCherry-ﬂuorescence intensity at 610 nm (in arbitrary
units, AU) from co-immunoprecipitations of each candidate with either eGFP-
srGAP3 or eGFP is plotted. For each sample, three to four independent experiments
were carried out (standard deviation is indicated). Asterisks mark samples in which
eGFP-srGAP3 and eGFP differ signiﬁcantly (P < 0.05 in unpaired t-test). SrGAP3,
which dimerises [19], served as positive control. GST was used as negative control.
The grey line marks the averaged background intensity of the instrument at
610 nm.
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of the multiple cloning site and eGFP or mCherry. The respective GI
numbers and restriction sites of all constructs are listed in the
Supplementary Table 1. The srGAP3 plasmid was a kind gift from
G. Rappold (Universität Heidelberg, Germany). Full-length human
srGAP3 (amino acids 1–1099, isoform 1) was subcloned into
pmCherryC2P and pEGFPC2P. Rat Amphiphysin, Endophilin-A1
(Hs), Endophilin-A2 (Hs), Grb2 (Hs), and GST were cloned into
pmCherryC2P. DNA constructs of Amphiphysin, Endophilin-A1,
and Endophilin-A2 were kindly provided by H.T. McMahon (MRC
Laboratory of Molecular Biology, United Kingdom). For expression
in Escherichia coli, the C-terminal region of srGAP3 (amino acids
810–1099) was cloned into the pETGST1c vector (provided by
Gunter Stier, Universität Heidelberg, Germany). The SH3 domains
and the srGAP3 PxxP-fragment (residues 1047–1079) were cloned
into pGEX6P1 (GE Healthcare). The mutant srGAP3 AxxA-fragment
(residues 1047–1079, P1056A/P1059A) was constructed through
cassette mutagenesis using a short ligation-ready fragmentobtained from ligation of phosphorylated oligonucleotides (see
Supplementary Table 1). The DNA sequence for the GFP-binding
protein [22] (subsequently abbreviated as GFP-nanobody) was
derived from the protein sequence published in [23,24]. A codon-
optimised DNA construct cloned into pET29a, including a C-term-
inal Thrombin cleavage site, was ordered from Genscript.
2.2. Mammalian cell culture
Adherent HEK293T cells [25] were cultured in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 lg/ml streptomycin, and 2 mM
L-Glutamine (Invitrogen) at 37 C in a humidiﬁed atmosphere with
5% CO2. Transient transfections were performed with polyethylen-
imine (PEI, linear, 25kDa, Sigma) [26] using a DNA/PEI ratio (w/v)
of 1/5.
2.3. Expression and puriﬁcation of proteins
SrGAP3-CTR was expressed in E. coli Rosetta 2 (DE3) cells, while
all other constructs were expressed in E. coli BL21-Gold (DE3).
Expression temperatures varied from 21 degree Celsius (all
srGAP3 constructs and EndophilinA1 SH3 domain) to 28 degree
Celsius (all other SH3 domains). SH3 domains and the short
srGAP3 fragments were puriﬁed with a Glutathione Sepharose 4B
column (GE Healthcare) under standard conditions and a size
exclusion chromatography step (Superdex 75, GE Healthcare).
The GST-tag was cleaved using PreScission protease (GE
Healthcare) prior (SH3 constructs) or after (srGAP3) gel ﬁltration.
The srGAP3 PxxP-fragment and the mutant thereof were further
puriﬁed via a second afﬁnity column. The ﬁnal storage buffer
contained 20 mM HEPES pH 7, 150 mM NaCl, and 3 mM b-
Mercaptoethanol. GST-srGAP3-CTR was puriﬁed via Glutathione
Sepharose afﬁnity chromatography, cation-exchange chro-
matography (Source S, GE Healthcare) as well as gel ﬁltration
(Superdex 200, GE Healthcare), and stored in 20 mM HEPES pH
6.8, 150 mM NaCl, and 3 mM b-Mercaptoethanol. A detailed puriﬁ-
cation protocol for this construct is included in the Supplementary
material. The GFP-nanobody was puriﬁed with Ni2+-NTA afﬁnity
chromatography and the free protein produced by cleavage of
the S-tag and the His6-tag with Thrombin (Sigma). Non-cleaved
protein was removed with a second Ni2+-NTA column and the
ﬂow-through subjected to a Superdex 75 column in 30 mM
HEPES pH 7, 150 mM NaCl and 3 mM b-Mercaptoethanol. Proper
folding of SH3 domains was assessed with circular dichroism (data
not shown).
2.4. GST pull-down and mass spectrometric analysis
GST pull-down with rat brain (P14) lysate was performed as
described by Rufer et al. [27] and bound proteins were analysed
by mass spectrometry. We utilised GST-srGAP3-CTR, GST-
srGAP1-CTR (Hs, residues 799–1085, kindly provided by A.
Jeganantham, MPI for Developmental Biology, Tübingen), and
GST for these experiments. Proteins were separated by SDS–PAGE
(Fig. S1) and gel sections were processed with in-gel tryptic digest
and subsequent NanoLC-MS/MS analysis by the Proteome Center
Tübingen. Data analysis was performed with the MaxQuant soft-
ware suite (version 1.0.14.3) [28] and the Mascot search engine
v.2.2 (Matrix Science). We then estimated the general conﬁdence
for the identiﬁcation of true binding partners based on peptide
counts and intensity. Proteins were counted as srGAP3-positive if
the number of peptides was at least twice as high as in control
experiments with srGAP1 and GST.
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MCherry-tagged candidate proteins were co-transfected with
either eGFP-srGAP3 full-length or eGFP into HEK293T cells and
harvested after 30 h. About 1  107 cells per sample were lysed in
10 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40
(Roche), 1 mM EDTA, 5 mM NaF, 3 mM Na4P2O7, 1 mM Na3VO4,
1 mM phenymethylsulfonyl ﬂuoride, and cOmplete Protease
Inhibitor Cocktail (Roche). Lysates were cleared by centrifugation
for 30 min at 13300 rpm and the volume between the sample
containing eGFP-srGAP3 and the control adjusted to yield equal
mCherry-ﬂuorescence (measured with BioTek H4 microplate
reader, Ex 590 nm/Em 610 nm). The constructs showed co-expression
in 70–90% of the cells as assessed by ﬂuorescence microscopy and
the protein expression was analysed by Western blotting. See
Fig. S2 for exemplary Western blots.
The correct discrimination of the GFP-nanobody between eGFP
and mCherry was conﬁrmed by isothermal titration calorimetry
(data not shown) as described in [24]. 1 mg/ml of nanobody was
covalently coupled to amino-reactive 96-well plates (Nunc
Immobilizer Amino Black, Thermo Scientiﬁc) in 100 mM sodium
carbonate buffer, pH 9.7, as described in the supplier’s protocol.
Unreacted sites were inactivated with ethanolamine. Nanobody-
containing plates were incubated with HEK293T lysates (4 replicates
per sample per plate) for 2 h at 4 C, washed twice with PBS-T (0.2%
Tween 20, Sigma), and the ﬂuorescence intensities were recorded
in PBS (BioTek Mx microplate reader, Ex 488 nm/Em 509 nm for
eGFP, Ex 580 nm/Em 610 nm for mCherry). The statistical analysis
of the data was performed with SigmaPlot (version 12.3, Systat
Software Inc.).
2.6. Isothermal titration calorimetry (ITC)
Measurements were carried out in a VP-ITC microcalorimeter
(MicroCal, Malvern Instruments) at 20 C. All proteins were exten-
sively dialysed against measurement buffer composed of 20 mM
HEPES, pH 6.8–7.3, 150 mM NaCl, and 5 mM b-Mercaptoethanol.
300 lM of SH3 domain was titrated into 30 lM GST-srGAP3-CTR.
Generally, 500–1000 lM of SH3 domain was titrated into 50–
100 lM srGAP3 PxxP-fragment or srGAP3 AxxA-fragment. Since
titrations of the C-terminal SH3 domain of Grb2 (Grb2 SH3C) into
the peptides resulted in non-reproducible binding isotherms, we
titrated 30 lM C-terminal Grb2 SH3C (in the cell) with 300 lM
srGAP3 PxxP-fragment or AxxA-fragment (in the syringe). All
experiments consisted of 27–28 injections à 10 ll with 240 s spac-
ing and constant stirring at 300 rpm. Data analysis was performed
with MicroCal Origin (version 7). The integrated heat signal was
corrected for the heat of dilution (obtained from reference titra-
tions of syringe component into buffer or GST) and analysed with
a single-site binding model.Table 1
SH3 domain-containing proteins identiﬁed by GST pull-down with srGAP3-CTR and srGAP1
only.
Protein Uniprot IDa Gene
Amphiphysin O08838 Amph
Endophilin-A1 O35179 Sh3gl2
Endophilin-A2 O35964 Sh3gl1
Growth factor receptor-bound protein 2 P62994 Grb2
a Indicated are the identiﬁer and the gene name from the Uniprot database: http://ww
calculated with ProtParam: http://web.expasy.org/protparam/.
b GST, Glutathione-S-Transferase tag, serves as negative control; CTR, C-terminal regi
srGAP1(Uniprot ID: Q7Z6B7).3. Results
3.1. Identiﬁcation of potential C-terminal binding partners of srGAP3
The C-terminal region of srGAP proteins is predicted to be dis-
ordered and motif searches employing the ELM resource (http://
elm.eu.org/ [29,30]) and Scansite (http://scansite3.mit.edu/home
[31,32]) revealed the presence of potential SH3 domain-binding
motifs (Fig. S3). It was reported that the spatial and temporal
expression pattern of srGAP3 is developmentally regulated
[33–35], which might similarly apply to expression patterns of
binding partners. Therefore and as we intended to identify cytoso-
lic srGAP3-binding proteins and srGAP3 mainly relocates to the
nucleus in the adult rat brain [35], we performed GST pull-downs
with brain lysate of rats at stage P14 (Fig. S1). The C-terminal
regions of srGAP1 and srGAP3 were tested in parallel in order to
detect srGAP3-speciﬁc binding partners with SH3 domains. Based
on mass spectrometry statistics and linear motif predictions for
srGAP3-CTR we identiﬁed four SH3 domain-containing proteins,
namely Amphiphysin, Endophilin-A1, Endophilin-A2, and Grb2,
that speciﬁcally interacted with GST-srGAP3-CTR but not GST
alone or GST-srGAP1-CTR (Table 1). Thus we chose to further
investigate the association of srGAP3 with these proteins.
3.2. SrGAP3 interacts with SH3 domain-containing proteins in vivo
In order to conﬁrm the direct interaction of srGAP3 with
Amphiphysin, Endophilin-A1, Endophilin-A2, and Grb2 in vivo,
we employed a ﬂuorescence-based co-immunoprecipitation assay
using N-terminally eGFP-tagged srGAP3 full-length and mCherry-
tagged candidate proteins transiently expressed in HEK293T cells
(compare [36]). The full-length sequence of srGAP3 was chosen,
since the protein dimerises via its N-terminal F-BAR domain
(Fig. 1A) [19], which increases local binding site concentration
and, thus, could strengthen otherwise weak monomeric
interactions. We found a signiﬁcant increase in the bound fraction
of all candidate proteins in co-immunoprecipitations with
eGFP-srGAP3 compared to the eGFP control (Fig. 1B), showing that
these proteins indeed interact with full-length srGAP3 in HEK293T
cells, while no interaction was observed between eGFP-srGAP3 and
mCherry-GST as negative control. To prove that complex formation
is in fact mediated by the C-terminal region of srGAP3, we
characterised the protein complexes in vitro.
3.3. The C-terminal region of srGAP3 confers binding to SH3 domains
As we expected that the SH3 domains of Amphiphysin,
Endophilin-A1, Endophilin-A2, and Grb2 (Fig. 2A) are mediating
complex formation, we measured the association of the isolated
SH3 domains with GST-srGAP3-CTR using ITC. We had to use a-CTR and subsequent mass spectrometric analysis. Listed are srGAP3-speciﬁc proteins
Peptidesa MWa [kDa]
GST-srGAP3-CTRb GST-srGAP1-CTRb GSTb
14 2 2 74.9
17 7 2 39.9
13 4 2 41.5
3 0 0 25.2
w.uniprot.org; the number of identiﬁed peptides; MW, theoretical molecular weight
on: residues 810–1099 of srGAP3 (Uniprot ID: O43295) and residues 799–1085 of
Fig. 2. GST-srGAP3-CTR directly interacts with SH3 domains. (A) Domain architecture of the srGAP3-interaction partners containing SH3 domains. N-BAR, Bin-Amphiphysin-
Rvs domain with additional N-terminal helix; SH3, Src-homology 3 domain; SH3N/SH3C, N-terminal and C-terminal SH3 domain, respectively; SH2, Src-homology 2 domain;
indicated in red are the SH3 domain construct boundaries. (B) Isothermal titrations of 300 lM SH3 domain into 30 lM GST-srGAP3-CTR (C-terminal region, residues 810–
1099 of srGAP3) or GST (exemplary titration of Endophilin-A2 SH3 is shown) at 20 C. The upper panel shows the raw heat signals (separated by shifting of the baselines),
whereas the lower panel displays the integrated heat signal per injection corrected for the heat of dilution (from titrating the SH3 domain into GST).
S. Wuertenberger, Y. Groemping / FEBS Letters 589 (2015) 1156–1163 1159GST-fusion protein as the CTR alone (which consists of 290 amino
acids and is mostly unfolded) was not stable over longer periods of
time. Our experiments demonstrated that the SH3 domains
of Endophilin-A1, Endophilin-A2, and the C-terminal SH3 domain
of Grb2 (Grb2 SH3C) directly bound to GST-srGAP3-CTR, but not
GST alone (Fig. 2B). The afﬁnities of the complexes for the
Endophilins A1 and A2 (Kd = 17–24 lM, Table 2) were in the range
expected for SH3 domain interactions (Kd = 1–100 lM, [37]). Grb2
SH3C produced non-reproducible isotherms when used at the high
concentrations that were required to observe an interaction. At
lower concentrations the resulting binding isotherm could not be
ﬁtted reliably. We therefore did not quantify this titration even
though a binding isotherm was detected (Table 2). The signal for
the interaction with the N-terminal SH3 domain of Grb2 (Grb
SH3N) (Fig. 2B) on the other hand was too weak to be analysed.
Binding of the CTR to Amphiphysin SH3 was undetectable with
our experimental settings (Fig. 2B, Table 2), which were limited
by the low solubility of GST-srGAP3-CTR. Importantly, since
srGAP3-CTR might contain multiple SH3-binding motifs and was
fused to a dimerising GST-tag to improve its stability, the
thermodynamic data of these complexes can only be considered
as qualitative. In summary, these results conﬁrmed that
Endophilin-A1, Endophilin-A2, and Grb2 directly interact with
srGAP3 and that these interactions are mediated by the C-terminal
region, presumably via short linear motifs.
3.4. Characterisation of a multi-class SH3-binding motif in the C-
terminal region of srGAP3
Interestingly, among all SH3-binding motifs predicted in
srGAP3-CTR (Fig. S3) only a single motif was predicted with high
conﬁdence by both, ELM and Scansite, under high stringency
settings: RPPPMRPVRP (residues 1053–1062, Fig. 3A). Polyproline
peptides usually bind in one of two orientations to SH3 domains
depending on the location of a positively charged amino acid
[38,39]: K/RxxPxxP (type I) and PxxPxR (type II). A unique feature
of the predicted srGAP3 motif is its multi-class nature in terms of
these type I and type II polyproline consensus sequences
(Fig. 3A), which might constitute a versatile interaction surface
for different SH3 domains. Moreover, the SH3 domain of
Amphiphysin was reported to speciﬁcally bind to the short linear
motif PSRPNR in the proline-rich region of Dynamin [40]. Since thissequence resembles the predicted SH3-binding motif of srGAP3 in
type II orientation (Fig. 3A), both conforming to the consensus
PxRPxR, we thought that Amphiphysin might likewise bind this
region in srGAP3. For this reason, we included the SH3 domain of
Amphiphysin in subsequent analyses, although we had failed to
detect complex formation between this SH3 domain and the full
CTR. We then prepared a shorter srGAP3 construct (amino acids
1047–1079, ‘‘PxxP fragment’’) comprising this linear motif and
tested in isothermal titrations if it could bind the SH3 domains of
Endophilin-A1, Endophilin-A2, Amphiphysin, and the C-terminal
SH3 domain of Grb2. We used an untagged version of the srGAP3
PxxP-fragment, as GST might sterically interfere with the
interaction due to the shortness of the peptide.
The short srGAP3 PxxP-fragment interacted with each of these
SH3 domains in a similar afﬁnity range (Kd = 14–27 lM) in a 1:1
stoichiometry (Fig. 3B–E, Table 2). Furthermore, the afﬁnities of
Endophilin-A1 SH3 and Endophilin-A2 SH3 were comparable to
titrations with the full CTR (Table 2). The enthalpic contribution
to complex formation between Amphiphysin SH3 and the
PxxP-fragment was small (Table 2), which explains why we failed
to detect this interaction at lower protein concentrations with the
full C-terminal region, where the signal remained below the detec-
tion limit. Interactions of Endophilin-A1 and Endophilin-A2
thermodynamically resembled each other (Table 2), which might
reﬂect similar complex interfaces. This could even be expected,
as the two domains share a high degree of sequence identity
(80%) and the residues lining the canonical SH3 domain binding
pocket are almost fully conserved [41]. In order to conﬁrm that
binding really depended on the predicted linear motif, we
conducted titrations with a mutated srGAP3 fragment, in which
the essential proline residues within the canonical binding
sequences, P1056 and P1059, were replaced by alanines (Fig. 3A,
‘‘srGAP3 AxxA-fragment’’). This mutant failed to bind any of the
four SH3 domains (Table 2, Fig. 3B–E). We also detected a signal
in titrations of the N-terminal SH3 domain of Grb2 with the
PxxP-fragment, but the binding enthalpy was too low to analyse
the isotherm (Table 2). Titration of this domain with the AxxA
mutant resulted in a similar signal (Fig. 3F), which points to a
non-speciﬁc interaction of Grb2-SH3N with the peptide. Taken
together, these results revealed that a single SH3-binding motif
in srGAP3-CTR was sufﬁcient for complex formation with different
SH3 domain-containing proteins.
Fig. 3. A single PXXP motif in srGAP3 mediates binding to four SH3 domains. (A) Location and amino acid sequence (+GPLGSCY from vector) of the puriﬁed srGAP3 PxxP-
fragment and the mutated AxxA-fragment (P1056A/P1059A). CC: predicted coiled-coil segment. The SH3-binding motif is highlighted in yellow and the mutated proline
residues are underlined. Indicated above are the type I and type II polyproline consensus sequences. (B–F) Interactions were measured with isothermal titration calorimetry
at 20 C. The upper panel shows the raw heat signal of titrations with the srGAP3 PxxP-fragment (residues 1047–1079) only. The lower panel shows the integrated heat signal
per injection corrected for the heat of dilution for the srGAP3 PxxP-fragment and the mutated AxxA-fragment. Binding isotherms were analysed assuming a single-site
binding model. Titrations were performed as follows: 1000 lM Endophilin-A1 SH3 into 100 lM srGAP3 PxxP-fragment or 100 lM srGAP3 AxxA-fragment (B), 1000 lM
Endophilin-A2 SH3 into 100 lM srGAP3 PxxP-fragment or 100 lM srGAP3 AxxA-fragment (C), 300 lM srGAP3 PxxP-fragment or srGAP3 AxxA-fragment were titrated into
30 lM C-terminal SH3 domain of Grb2 (Grb2 SH3C) (D), 1000 lM Amphiphysin SH3 into 100 lM srGAP3 PxxP-fragment or 100 lM srGAP3 AxxA-fragment (E), and
500 lMN-terminal SH3 domain of Grb2 (Grb2 SH3N) into 50 lM srGAP3 PxxP-fragment or 50 lM srGAP3 AxxA-fragment (F). In titrations with Grb2 SH3C syringe and cell
components were switched due to reduced stability of the SH3 domain at high concentrations which resulted in non-reproducible binding isotherms.
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Transient protein–protein interactions are pivotal to the major-
ity of signalling processes and often involve binding of structured
domains to linear motifs [2]. The typically low afﬁnity and promis-
cuous nature of these linear motif interactions [4] predispose them
to fulﬁll the requirements inherent in signal transduction:
reversibility and the ability to integrate signals coming from
different pathways [2,4,42]. Employing a ﬂuorescence-based
co-immunoprecipitation assay, we identiﬁed four new interaction
partners of srGAP3 in vivo: Endophilin-A1, Endophilin-A2,
Amphiphysin, and Grb2. We further showed by isothermal
titrations that a single proline-rich motif (RPPPMRPVRP) in the
presumably disordered C-terminal region of srGAP3 is sufﬁcient
for the direct interaction with the SH3 domains of Endophilins,
Amphiphysin, and Grb2. The complexes between a short srGAP3-
fragment containing this motif and the isolated SH3 domains of
either Endophilin-A1, Endophilin-A2, Amphiphysin, or Grb2 SH3C
exhibited similar afﬁnities and occurred in a one-to-one fashion.
And although all these interactions depended on one PxxP motif,
they might feature slightly different or overlapping interfaces:
The SH3 domain of Amphiphysin was, for example, reported tospeciﬁcally recognise type II motifs containing two arginines (con-
sensus PxRPxR) [40], which is comprised in the srGAP3 sequence
(RPPPMRPVRP). The afﬁnity of this interaction is three times higher
than the previously reported afﬁnity of the Amphiphysin-Dynamin
complex [43], rendering it the strongest interaction for the isolated
Amphiphysin SH3 domain and a peptide ligand described so far.
The binding speciﬁcity of the SH3 domains of Endophilins were
reported to be more complex [44,45], with certain preference for
arginine in position + 2 relative to the ﬁrst proline in the PxxP
consensus [44,46], and these SH3 domains could therefore
recognise the type I or type II orientation of the motif in srGAP3.
The interaction of Grb2 was guided by its C-terminal SH3
domain and Grb2 SH3C was shown to interact with a PxxxRxxKP
motif [47], in which the RxxK consensus is crucial for binding
[48], as well as type II motifs followed by two arginines [49]. The
srGAP3 motif RPPPMRPVRP diverges from both of these consensus
sequences and, thus, the speciﬁcity-determining residues remain
to be identiﬁed. However, mutation of two proline residues
(RPPPMRPVRP) instead of the two arginines abrogated binding,
which argues in favour of the canonical type II motif. In summary,
we identiﬁed a single proline-rich motif in srGAP3, which displays
an unexpected ﬂexibility in adapting to different SH3-binding
Table 2
Thermodynamic data from isothermal titrations of SH3 domains and various srGAP3 fragments.
SH3 Domain SrGAP3 Fragment Kda [lM] Na DH(obs)a [kcal/mol] TDS(obs)a [kcal/mol]
Endophilin-A1 SH3
Endophilin-A1 SH3 GST-srGAP3-CTRb 17 ± 1 1.1 ± 0.0 9.8 ± 0.2 3.4 ± 0.3
Endophilin-A1 SH3 srGAP3 PxxP-fragmentb 17 ± 1 1.0 ± 0.0 9.3 ± 0.1 2.9 ± 0.1
Endophilin-A1 SH3 srGAP3 AxxA-fragmentb n.d.b n.d. n.d. n.d.
Endophilin-A2 SH3
Endophilin-A2 SH3 GST-srGAP3-CTR 24 ± 3 0.7 ± 0.1 12.0 ± 1.3 5.8 ± 1.4
Endophilin-A2 SH3 srGAP3 PxxP-fragment 20 ± 1 1.1 ± 0.3 8.5 ± 0.3 2.2 ± 0.3
Endophilin-A2 SH3 srGAP3 AxxA-fragmentb n.d. n.d. n.d. n.d.
Amphiphysin SH3
Amphiphysin SH3 GST-srGAP3-CTR n.d. n.d. n.d. n.d.
Amphiphysin SH3 srGAP3 PxxP-fragment 27 ± 6 1.2 ± 0.1 1.4 ± 0.4 4.7 ± 0.5
Amphiphysin SH3 srGAP3 AxxA-fragment n.d. n.d. n.d. n.d.
Grb2 SH3N
Grb2 SH3Nb GST-srGAP3-CTR NQc NQ NQ NQ
Grb2 SH3N srGAP3 PxxP-fragment NQ NQ NQ NQ
Grb2 SH3N srGAP3 AxxA-fragment NQ NQ NQ NQ
Grb2 SH3C
Grb2 SH3Cb GST-srGAP3-CTR NQ NQ NQ NQ
Grb2 SH3C srGAP3 PxxP-fragment 14 ± 5 1.2 ± 0.1 4.7 ± 1.8 1.9 ± 1.6
Grb2 SH3C srGAP3 AxxA-fragment n.d. n.d. n.d. n.d.
a Analysis performed with single-site binding model; Kd = dissociation constant; N = stoichiometry (syringe component to cell component); DH(obs) = observed binding
enthalpy; TDS(obs) = observed binding entropy derived from Kd and DH(obs). Indicated is the standard deviation between 2 and 3 independent experiments. Grb2 SH3N and
Grb2 SH3C were measured only once due to limited availability of GST-srGAP3-CTR.
b GST-srGAP3-CTR: srGAP3 (residues 810–1099) N-terminally tagged with GST; n.d., not detected; srGAP3 PxxP-fragment: residues 1047–1079; srGAP3 AxxA-fragment:
residues 1047–1079 with mutation of P1056 and P1059 to alanine; SH3N: N-terminal SH3 domain; SH3C: C-terminal SH3 domain.
c NQ: not quantiﬁable.
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srGAP3 proteins, but is absent from srGAP1 and srGAP2 in terms
of type I and type II polyproline consensus sequences (Fig. S3),
which potentially renders the interactions speciﬁc for srGAP3.
How membrane conﬁnement through BAR domains [19,50] or
the ability of all identiﬁed proteins to dimerise [19,50–53] will
affect the afﬁnity of the respective complexes in the context of
multi-protein networks inside the cell [1], remains, however, to
be shown.
With respect to cellular functions, Endophilins and
Amphiphysin belong to the clathrin-dependent endocytic machin-
ery [54–57], whereas Grb2 is implicated in growth factor receptor
signalling via Ras [58–62] and associated receptor-uptake mecha-
nisms [63–65]. Therefore, srGAP3 could play an analogous role in
endocytic processes as the BAR domain-containing Rho-GAP pro-
tein Oligophrenin1 [66]. Oligophrenin1 has been found to recruit
Endophilins via a similar proline-rich motif located in the C-term-
inal proline-rich region, thereby promoting synaptic vesicle uptake
and AMPA receptor internalisation [67,68]. Here, we provide ﬁrst
evidence that the CTR of srGAP3 might function as an adaptor
platform connecting srGAP3 and therefore its targets – like the
Robo receptor – to different protein networks, namely the endocytic
machinery.
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